Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03389100Phase 2Enrolling By Invitation

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

Role: collaborator

NCT03383289Not ApplicableCompleted

Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living

Role: lead

NCT02092987Not ApplicableCompleted

Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study

Role: collaborator

NCT01918891Not ApplicableCompleted

Center for Stroke Disparities Solution - Community Transitions Intervention

Role: collaborator

NCT00579618Completed

Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging

Role: collaborator

NCT01070056Phase 3Completed

Practice-based Trial of Blood Pressure Control in African Americans

Role: collaborator

All 6 trials loaded